TerminatedPHASE1, PHASE2NCT00358423
The Effect of Macugen in Patients With Chronic, Post-Operative Cystoid Macular Edema
Studying Cystoid macular dystrophy
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Johns Hopkins University
- Principal Investigator
- Diana V. Do, MDJohns Hopkins University
- Intervention
- Pegaptanib Sodium(drug)
- Enrollment
- 1 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2006 – 2007
Study locations (1)
- The Johns Hopkins Hospital, Baltimore, Maryland, United States
Collaborators
Eyetech Pharmaceuticals
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT00358423 on ClinicalTrials.govOther trials for Cystoid macular dystrophy
Additional recruiting or active studies for the same condition.